FDA Panel Favors Expanding Approval for Diabetes Injection Drug to Treat Obesity
September 11, 2014
(Associated Press) – Federal health experts say Novo Nordisk’s diabetes drug Victoza should be approved for a new use in treating obesity. The panel of Food and Drug Administration advisers voted 14-1 that the injectable drug’s benefits outweigh its risks for patients who are obese or dangerously overweight.